Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-16 · accession 0001493152-25-013918 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-17 | 2025-09-16 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $1.97 | +2,600 | 290.7K | +0.9% | +$5,122 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | P | A | 2,600 | $1.97 | 290,659 | D | — | — |